Denali Therapeutics Inc. Contracts & Agreements

57 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of the Registrants Common Stock
Stock Agreements
Denali Therapeutics Inc.
Biotechnology
2022
Denali - Biogen Side Letter
Denali Therapeutics Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Denali Therapeutics Inc.
2024
Description of the Registrants Common Stock
Stock Agreements
Denali Therapeutics Inc.
2024
Compensation Recovery Policy (Clawback Policy)
Compensation Agreements
Denali Therapeutics Inc.
2024
Denali Insider Trading Policy and Guidelines with Respect to Certain Transactions in Securities as amended through March 31, 2023
Denali Therapeutics Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Denali Therapeutics Inc.
2024
Securities Purchase Agreement, dated February
Purchase Agreements
Denali Therapeutics Inc.
2024
Nominating Agreement by and among the Company and Investor
Denali Therapeutics Inc.
2024
Amendment to Definitive LRRK2 Agreement and Waiver of and Amendment to Right of First Negotiation, Option, and License Agreement
License Agreements
Denali Therapeutics Inc.
2023
Amendment No. 9 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated December 7, 2022
Sales Agreements
Denali Therapeutics Inc.
Biotechnology
2023
Amendment No. 8 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 8, 2022
Sales Agreements
Denali Therapeutics Inc.
Biotechnology
2023
Amendment No. 7 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated March 29, 2021
Sales Agreements
Denali Therapeutics Inc.
Biotechnology
2023
Description of the Registrants Common Stock
Stock Agreements
Denali Therapeutics Inc.
2023
Underwriting Agreement, dated as of October
Underwriting Agreements
Denali Therapeutics Inc.
2022
Equity Distribution Agreement between the Company and Goldman Sachs & Co. LLC, SVB Securities LLC and Cantor Fitzgerald & Co., dated as of February 28, 2022
Equity Distribution Agreements
Denali Therapeutics Inc.
Biotechnology
NY
2022
Amended and Restated Outside Director Compensation Policy
Compensation Agreements
Denali Therapeutics Inc.
2022
Side Letter between the Registrant and F-star Gamma Limited, dated June 30, 2021
Denali Therapeutics Inc.
2021
Amended and Restated Outside Director Compensation Policy
Compensation Agreements
Denali Therapeutics Inc.
2021
Amendment No. 6 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October...
Sales Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Amendment No. 3 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October...
Sales Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Amendment No. 5 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October...
Sales Agreements
Denali Therapeutics Inc.
2021
Amended and Restated Outside Director Compensation Policy
Compensation Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Description of the registrants common stock
Stock Agreements
Denali Therapeutics Inc.
Biotechnology
2021
Form of Amended and Restated Change in Control and Severance Plan
Change of Control Agreements
Denali Therapeutics Inc.
2020
Definitive R
Denali Therapeutics Inc.
2020
Definitive LRRK2 Collaboration and License Agreement
Collaboration Agreements
Denali Therapeutics Inc.
Biotechnology
2020
Standstill and Stock Restriction Agreement between the Registrant and Biogen Inc., dated September 22, 2020
Stock Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2020
Provisional LRRK2 Collaboration and License Agreement between the Registrant and Biogen Inc., dated August 5, 2020
Collaboration Agreements
Denali Therapeutics Inc.
2020
Common Stock Purchase Agreement between the Registrant and Biogen Inc., dated August 5, 2020
Stock Agreements
Denali Therapeutics Inc.
2020
Amended and Restated Outside Director Compensation Policy
Compensation Agreements
Denali Therapeutics Inc.
2020
Description of the registrants common stock
Stock Agreements
Denali Therapeutics Inc.
Biotechnology
2020
Underwriting Agreement, dated as of January 28, 2020, among Denali Therapeutics Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Jefferies LLC, as representatives...
Underwriting Agreements
Denali Therapeutics Inc.
2020
Amendment No. 3 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October...
Sales Agreements
Denali Therapeutics Inc.
Biotechnology
2018
Amendment No. 4 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October...
Sales Agreements
Denali Therapeutics Inc.
Biotechnology
2018
First Amendment to Lease between the Registrant and HCP Oyster Point III LLC, dated May 2, 2018
Lease Agreements
Denali Therapeutics Inc.
2018
Amended and Restated Licence Agreement between F-star Gamma Limited and F-star Biotechnology Limited, dated August 24, 2016
Denali Therapeutics Inc.
2018
Side Letter between the Registrant, F-Star Gamma Limited, F-Star Biotechnology Limited and f-star Biotechnologische Forschungs-und Entwicklungsges m.b.H., dated May 21, 2018
Denali Therapeutics Inc.
2018
Share Purchase Agreement between the Registrant, certain shareholders of F-star Gamma Limited and Shareholder Representative Services LLC, dated May 30, 2018
Share Agreements
Denali Therapeutics Inc.
2018
Standstill and Stock Restriction Agreement between the Registrant and Takeda Pharmaceutical Company Limited, dated February 23, 2018
Stock Agreements
Denali Therapeutics Inc.
2018
Amendment No. 2 to Development and Manufacturing Services Agreement between the Registrant and Lonza Sales AG, dated September 6, 2017, as amended by Amendment No. 1 on October...
Sales Agreements
Denali Therapeutics Inc.
2018
Option and Collaboration Agreement between the Registrant and Takeda Pharmaceutical Company Limited, dated January 3, 2018
Collaboration Agreements
Denali Therapeutics Inc.
2018
Common Stock Purchase Agreement between the Registrant and Takeda Pharmaceutical Company Limited, dated January 3, 2018
Stock Agreements
Denali Therapeutics Inc.
2018
2017 Employee Stock Purchase Plan and form of agreement thereunder, to be in effect upon the completion of this offering
Stock Agreements
Denali Therapeutics Inc.
Biotechnology
CA
2017
Form of Underwriting Agreement, including Form of Lock-up Agreement
Underwriting Agreements
Denali Therapeutics Inc.
Biotechnology
2017
2017 Employee Stock Purchase Plan and form of agreement thereunder, to be in effect upon the completion of this offering
Stock Agreements
Denali Therapeutics Inc.
Biotechnology
CA
2017
2017 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering
Bonus & Incentive Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2017
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
Indemnification Agreements
Denali Therapeutics Inc.
2017
Specimen common stock certificate of the Registrant
Stock Agreements
Denali Therapeutics Inc.
2017
Offer Letter between the Registrant and Carole Ho, M.D., dated November 10, 2017
Denali Therapeutics Inc.
2017
Lease Agreement between the Registrant and HCP Oyster Point III LLC, dated September 24, 2015
Lease Agreements
Denali Therapeutics Inc.
Biotechnology
CA
2017
Exclusive License Agreement between the Registrant and Genentech, Inc., dated June 17, 2016
License Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2017
Offer Letter between the Registrant and Steve E. Krognes, dated November 10, 2017
Denali Therapeutics Inc.
2017
Offer Letter between the Registrant and Alexander O. Schuth, M.D., dated November 10, 2017
Denali Therapeutics Inc.
2017
Offer Letter between the Registrant and Ryan J. Watts, Ph.D., dated November 10, 2017
Denali Therapeutics Inc.
2017
2015 Stock Incentive Plan, as amended, and forms of agreement thereunder
Bonus & Incentive Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2017
Investors Rights Agreement among the Registrant and certain of its stockholders, dated May 8, 2015, as amended on June 4, 2015, July 22, 2015 and June 22, 2016
Investor Rights Agreements
Denali Therapeutics Inc.
Biotechnology
DE
2017